I now have comprehensive content from both the ENT (Cummings Otolaryngology) and Internal Medicine (Harrison's) textbooks. Let me synthesize this into a thorough answer covering all requested topics.
Sinusitis: Comprehensive Clinical Overview
1. Anatomy of the Paranasal Sinuses
The paranasal sinuses are four paired air-filled cavities — maxillary, frontal, ethmoid, and sphenoid — lined with pseudostratified ciliated columnar epithelium (respiratory mucosa).
Key Anatomical Relationships
| Sinus | Location | Drainage |
|---|
| Maxillary | Body of maxilla; roof = orbital floor, floor = hard palate, medial wall = lateral nasal wall | Natural ostium → middle meatus (high on medial wall, anti-gravity) |
| Frontal | Above orbits in frontal bone | Frontal recess → middle meatus |
| Ethmoid | Between orbit and nasal cavity (anterior & posterior groups) | Anterior → middle meatus; posterior → superior meatus |
| Sphenoid | Body of sphenoid, posterior nasal cavity | Sphenoethmoidal recess → posterior nasal cavity |
Ostiomeatal Complex (OMC)
The OMC is the functional drainage pathway of the anterior sinuses (maxillary, anterior ethmoid, frontal). It comprises the maxillary ostium, uncinate process, ethmoid infundibulum, and middle meatus. Obstruction at this anatomical bottleneck is central to the pathogenesis of most sinusitis.
Critical Anatomical Landmarks
- Lamina papyracea: thin bony medial orbital wall, separating the ethmoid sinuses from the orbit — key route for orbital complications
- Cribriform plate / fovea ethmoidalis: the cribriform plate may be only 0.1–0.2 mm thick; its depth is classified by the Keros classification (type I: 1–3 mm; type II: 4–7 mm; type III: 8–16 mm). Type III carries the highest risk of intracranial penetration during surgery
- Anterior ethmoidal artery: lies posterior to the frontal recess; injury causes retraction into the orbit → acute orbital hematoma → blindness
- Anterior skull base: highest anteriorly, slopes downward posteriorly — relevant during ethmoidectomy
2. Pathogenesis
Sinusitis (more accurately rhinosinusitis, as the nasal mucosa is virtually always involved) results from a cascade of mucosal inflammation, impaired drainage, and secondary infection.
Initiating Factors
- Viral upper respiratory infections account for the vast majority of acute cases. Viruses damage ciliated epithelium, increase mucus viscosity, and cause mucosal edema → ostial obstruction
- Allergic rhinitis: eosinophilic inflammation → mucosal edema → OMC obstruction
- Anatomical factors: deviated nasal septum, hypertrophied turbinates, nasal polyps, agger nasi cells, concha bullosa
- Iatrogenic: nasotracheal intubation (nosocomial sinusitis in ICU patients), facial trauma
- Immunodeficiency / ciliary dyskinesia / cystic fibrosis: impair mucociliary clearance
Mechanism
- Mucosal edema (viral/allergic) obstructs the OMC
- Reduced sinus ventilation → hypoxia, decreased ciliary function, mucus accumulation
- Bacterial colonization and overgrowth in the anaerobic, stagnant environment
- Persistent inflammation → mucosal remodeling, polyp formation (chronic disease)
Microbiology
| Type | Organisms |
|---|
| Acute bacterial | S. pneumoniae, H. influenzae, M. catarrhalis |
| Chronic | S. aureus, gram-negative rods, anaerobes, fungi |
| Invasive fungal | Mucorales spp. (mucormycosis), Aspergillus — immunocompromised hosts |
| Nosocomial | Polymicrobial, gram-negatives |
Key fact: Only <2% of acute sinusitis episodes are bacterial in etiology, yet antibiotics are prescribed in >70% of office visits — making this a major driver of inappropriate antibiotic prescribing.
— Harrison's Principles of Internal Medicine
3. Classification and Clinical Features
Acute Sinusitis (<4 weeks)
Symptoms: purulent nasal discharge, facial pain/pressure/congestion, fever, hyposmia/anosmia, postnasal drip, maxillary toothache, halitosis, ear fullness, fatigue.
Examination: rhinoscopy shows excess mucus or purulence; tenderness over affected sinuses; in severe cases, erythema and swelling of the maxilla.
Subacute Sinusitis (4–12 weeks)
Transitional category; persistent symptoms beyond viral resolution, often requiring re-evaluation.
Recurrent Acute Sinusitis
≥4 episodes/year with complete resolution between episodes. Warrants workup for anatomical predisposing factors, allergic evaluation, immunologic assessment.
Chronic Sinusitis (>12 weeks)
Cardinal symptoms: facial pressure/pain, mucopurulent discharge, nasal congestion, hyposmia/anosmia. Also: fatigue, cough, ear pressure.
Three main subtypes (in decreasing frequency):
- Chronic sinusitis without polyps — more common in women; TH1-predominant; associated with bacterial infection/colonization
- Chronic sinusitis with polyps — more common in men; TH2/eosinophilic; associated with asthma and aspirin sensitivity (Samter's triad)
- Allergic fungal rhinosinusitis (AFRS) — warm/humid regions; atopic individuals; IgE-mediated; characteristic greenish-brown "peanut butter" mucin with fungal hyphae (usually Aspergillus); resistant to medical treatment
Invasive Fungal Sinusitis
A medical/surgical emergency in immunocompromised patients (uncontrolled diabetes, transplant recipients). Presents as rapidly progressive rhinosinusitis → facial pain → cranial nerve involvement → orbital swelling, proptosis, chemosis, ophthalmoplegia. Evaluation: nasal endoscopy with biopsy + gadolinium-enhanced MRI.
4. Treatment
Acute Sinusitis
Symptomatic (all patients):
- Intranasal decongestants: oxymetazoline 2 sprays each nostril BID × ≤5 days (rebound risk)
- Oral decongestants: pseudoephedrine 120 mg (12-h formulation)
- Analgesics/antipyretics: acetaminophen or NSAIDs (ibuprofen)
- Nasal saline sprays and washes
- Intranasal glucocorticoids (especially if allergic component)
Antibiotics — prescribing criteria (any one of):
| Indication | Definition |
|---|
| Persistent | Symptoms lasting ≥10 days |
| Severe | Fever >102°F + purulent nasal discharge or nasal pain ≥3–4 consecutive days |
| Worsening | New fever, headache, or increased nasal discharge after initial improvement following 5–6 days of URI |
Only ~20–50% of adults with sinusitis meet these criteria for antibiotic prescribing.
Antibiotic regimens:
- First-line: Amoxicillin-clavulanate 875/125 mg PO BID × 7 days
- Alternative: Amoxicillin 875 mg PO BID × 7 days
- Mild penicillin allergy: Cefuroxime
- Severe penicillin allergy: Doxycycline
- Note: Macrolides are not recommended due to high rates of macrolide-resistant S. pneumoniae
- No improvement after 3–5 days: Second-line — amoxicillin-clavulanate 2000/125 mg BID or levofloxacin (note: fluoroquinolones carry risks of dysglycemia, neuropathy, tendon and aortic rupture)
- Failure of second-line: Refer to otorhinolaryngologist; noncontrast CT imaging
Special situations:
- Invasive fungal sinusitis: IV antifungal agents + surgical debridement
- Nosocomial sinusitis: Remove precipitating factors (e.g., nasotracheal tube) + broad-spectrum antibiotics pending cultures
Chronic Sinusitis
- Trigger avoidance: allergens, smoke, irritants
- Nasal saline washes (higher volume = more effective)
- Intranasal glucocorticoids: mometasone, fluticasone sprays; budesonide rinses (for polyps) — cornerstone of therapy; reduce polyp size
- Oral glucocorticoids: 2–3-week course for patients unresponsive to topical steroids, especially those with polyps
- Antihistamines (intranasal or systemic) for allergic component
- Leukotriene antagonists: montelukast (especially with aspirin sensitivity)
- Antibiotics: 2–4 weeks commonly prescribed, but limited evidence; 3 months of macrolide therapy has modest evidence for patients without polyps
- Biologic therapy: Dupilumab (anti-IL-4/IL-13), mepolizumab (anti-IL-5), and omalizumab (anti-IgE) are approved options for severe chronic sinusitis with polyps refractory to standard therapy
- Surgery: Functional Endoscopic Sinus Surgery (FESS) — restores patency of the OMC, removes obstructing cells/polyps, improves mucociliary drainage. Caldwell-Luc procedure (canine fossa approach) has limited modern indications (complicated acute/chronic CRS, foreign bodies, benign tumors)
5. Rhinogenic Orbital Complications
The orbit is separated from the ethmoid sinuses only by the thin lamina papyracea. Orbital complications occur most commonly from ethmoid sinusitis (especially in children), followed by frontal sinusitis.
Chandler Classification of Orbital Complications (5 stages)
| Stage | Name | Description |
|---|
| I | Preseptal (periorbital) cellulitis | Inflammatory edema anterior to the orbital septum; no proptosis or limitation of eye movement |
| II | Orbital cellulitis | Diffuse edema of orbital fat, posterior to the orbital septum; mild proptosis, chemosis; no discrete abscess |
| III | Subperiosteal abscess | Pus between the periorbita and lamina papyracea; proptosis, gaze limitation toward the side of abscess |
| IV | Orbital abscess | Pus within the orbital fat; marked proptosis, complete ophthalmoplegia, chemosis, visual impairment |
| V | Cavernous sinus thrombosis | Spread beyond the orbit; bilateral involvement, high fever, prostration, meningeal signs |
Clinical warning signs of orbital complication: proptosis, periorbital edema/erythema, limited ocular movement, diplopia, reduced visual acuity, chemosis.
Management:
- Stages I–II: IV antibiotics (covers S. aureus, streptococci, gram-negatives), close monitoring of vision
- Stages III–V: Urgent surgical drainage (endoscopic or external approach) + IV antibiotics; ophthalmology co-management. Loss of visual acuity mandates emergency intervention.
6. Rhinogenic Intracranial Complications
Intracranial spread occurs via direct bony erosion, retrograde thrombophlebitis through the diploe veins (valveless), or hematogenous spread. Frontal sinusitis is the most common precursor.
Types of Intracranial Complications
| Complication | Key Features |
|---|
| Meningitis | Most common; headache, fever, nuchal rigidity, photophobia; CSF confirms diagnosis |
| Epidural abscess | Between dura and skull; often silent until large; CT/MRI diagnosis |
| Subdural empyema | Surgical emergency; spreads freely in subdural space; seizures, focal deficits, rapid deterioration; high mortality |
| Cerebral abscess | Frontal lobe most commonly; headache, focal deficits, personality change |
| Cavernous sinus thrombosis | Via orbital veins from ethmoid/frontal sinusitis; bilateral proptosis, ophthalmoplegia (CN III, IV, VI palsy), chemosis, high fever, septicemia; high mortality |
| Superior sagittal sinus thrombosis | From frontal sinusitis; raised ICP, papilledema, seizures |
| Pott's puffy tumor | Subperiosteal abscess of the frontal bone with underlying osteomyelitis; soft fluctuant forehead swelling — a classic but now rare complication of frontal sinusitis |
New symptoms suggesting intracranial complication: confusion, unilateral weakness, proptosis, limited ocular movements, acute vision changes, severe worsening headache.
Imaging: Contrast-enhanced CT (first-line for bony erosion and acute abscess); gadolinium MRI preferred for soft tissue detail, cavernous sinus thrombosis, and subdural empyema.
Management: High-dose IV antibiotics + urgent neurosurgical consultation. Subdural empyema and large cerebral abscesses require surgical drainage. Cavernous sinus thrombosis requires anticoagulation in addition to antibiotics.
Summary Table: Complications of Sinusitis
| Category | Specific Complication | Source Sinus |
|---|
| Orbital | Preseptal cellulitis → orbital abscess → cavernous sinus thrombosis | Ethmoid > Frontal |
| Intracranial | Meningitis, epidural/subdural abscess, cerebral abscess | Frontal > Ethmoid |
| Osseous | Osteomyelitis, Pott's puffy tumor | Frontal |
| Vascular | Cavernous sinus thrombosis, sagittal sinus thrombosis | Ethmoid, Frontal |
Sources:
- Cummings Otolaryngology: Head and Neck Surgery, 7th ed. — anatomy, surgical management (ESS, Caldwell-Luc, frontal sinusotomy)
- Harrison's Principles of Internal Medicine — clinical classification, antibiotic criteria, treatment algorithms, complications overview